| HOME >> BIOLOGY >> TECHNOLOGY |
1,017 44 1,083 88
INCOME (LOSS) BEFORE INCOME TAXES 247 (258) (1,017) (544)
INCOME TAX EXPENSE 14 -- 19 17
INCOME (LOSS) FROM CONTINUING
OPERATIONS 233 (258) (1,036) (561)
INCOME (LOSS) FROM DISCONTINUED
OPERATIONS, NET OF TAX (7) (125) 66 (139)
NET INCOME (LOSS) $226 $(383) $(970) $(700)
BASIC AND DILUTED INCOME (LOSS)
PER SHARE:
From continuing operations $0.00 $(0.01) $(0.02) $(0.01)
From discontinued operations 0.00 0.00 0.00 0.00
$0.00 $(0.01) $(0.02) $(0.01)
BASIC WEIGHTED AVERAGE SHARES
OUTSTANDING 49,189,672 49,189,672 49,189,672 49,187,211
DILUTED WEIGHTED AVERAGE
SHARES OUTSTANDING 62,141,863 49,189,672 49,189,672 49,187,211
Transgenomic, Inc.
Summary Financial Results
Unaudited Condensed Consolidated Statements of Cash Flows
(Dollars in thousands)
Six Months
Ended
June 30,
2007 2006
NET CASH FLOWS PROVIDED BY (USED IN) OPERATING
ACTIVITIES (1,564) 665
NET CASH FLOWS PROVIDED BY (USED IN) INVESTING
ACTIVITIES 3,572 (179)
NET CASH FLOWS PROVIDED BY FINANCING
ACTIVITIES
'/>"/>
SOURCE Transgenomic, Inc.![]() Copyright©2007 PR Newswire. |